{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:35:12Z","timestamp":1794724512478,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.biopha.2021.111385","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T12:00:59Z","timestamp":1614427259000},"page":"111385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["In vivo bioavailability and in vitro toxicological evaluation of the new butyric acid releaser N-(1-carbamoyl-2-phenyl-ethyl) butyramide"],"prefix":"10.1016","volume":"137","author":[{"given":"Roberto","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Santarcangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Badolati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Sommella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Dacrema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Campiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Stornaiuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Daglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111385_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/advances\/nmx009","article-title":"Butyrate: a double-edged sword for health?","volume":"9","author":"Liu","year":"2018","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.biopha.2021.111385_bib2","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/obr.12068","article-title":"Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?","volume":"14","author":"Brahe","year":"2013","journal-title":"Obes. Rev."},{"key":"10.1016\/j.biopha.2021.111385_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuint.2016.06.011","article-title":"The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis?","volume":"99","author":"Stilling","year":"2016","journal-title":"Neurochem Int."},{"key":"10.1016\/j.biopha.2021.111385_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3920\/BM2010.0041","article-title":"Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics","volume":"1","author":"Bird","year":"2010","journal-title":"Benef. Microbes"},{"key":"10.1016\/j.biopha.2021.111385_bib5","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1039\/c3fo60052a","article-title":"Effects of dietary fibers and their mixtures on short chain fatty acids and microbiota in mice guts","volume":"4","author":"Peng","year":"2013","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2021.111385_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/gut.48.1.53","article-title":"Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats","volume":"48","author":"Perrin","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2021.111385_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2036.2007.03562.x","article-title":"The role of butyrate on colonic function","volume":"27","author":"Hamer","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2021.111385_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev-physiol-021909-135817","article-title":"Role of colonic short-chain fatty acid transport in diarrhea","volume":"72","author":"Binder","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.biopha.2021.111385_bib9","article-title":"In vitro fermentation profile of soluble dietary fibers obtained by different enzymatic extractions from barley bran","volume":"21","author":"Karimi","year":"2020","journal-title":"Bioact. Carbohydr. Diet. Fibre"},{"key":"10.1016\/j.biopha.2021.111385_bib10","article-title":"Potential beneficial effects of butyrate in intestinal and extraintestinal diseases","volume":"17","author":"Berni Canani","year":"2011","journal-title":"WJG"},{"key":"10.1016\/j.biopha.2021.111385_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.biortech.2018.01.007","article-title":"Recent advances and strategies in process and strain engineering for the production of butyric acid by microbial fermentation","volume":"253","author":"Luo","year":"2018","journal-title":"Bioresour. Technol."},{"key":"10.1016\/j.biopha.2021.111385_bib12","first-page":"295","article-title":"Butyric acid in functional constipation","volume":"8","author":"Pituch","year":"2013","journal-title":"Prz. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.111385_bib13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1469-7793.1998.719ba.x","article-title":"Identification and characterization of a monocarboxylate transporter (MCT1) in pig and human colon: its potential to transport l\u2010lactate as well as butyrate","volume":"513","author":"Ritzhaupt","year":"1998","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2021.111385_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2016.02.009","article-title":"Butyrate, neuroepigenetics and the gut microbiome: can a high fiber diet improve brain health?","volume":"625","author":"Bourassa","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2021.111385_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1139\/H09-119","article-title":"The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects","volume":"35","author":"Tarini","year":"2010","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"10.1016\/j.biopha.2021.111385_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/1868-7083-4-4","article-title":"The epigenetic effects of butyrate: potential therapeutic implications for clinical practice","volume":"4","author":"Berni Canani","year":"2012","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.biopha.2021.111385_bib17","series-title":"In Epigenetic Cancer Therapy","first-page":"393","article-title":"Nutritional epigenetic regulators in the field of cancer: new avenues for chemopreventive approaches","author":"Schnekenburger","year":"2015"},{"key":"10.1016\/j.biopha.2021.111385_bib18","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/003655202317316105","article-title":"Butyrate inhibits NF-\u03baB activation in lamina propria macrophages of patients with ulcerative colitis","volume":"37","author":"L\u00fchrs","year":"2002","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.111385_bib19","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1096\/fj.00-0359fje","article-title":"Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production","volume":"14","author":"S\u00e4emann","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2021.111385_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbrc.2003.08.026","article-title":"Butyrate modulates gene and protein expression in human intestinal endothelial cells","volume":"309","author":"Ogawa","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2021.111385_bib21","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1096\/fj.14-259598","article-title":"Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells","volume":"29","author":"Reigstad","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2021.111385_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2021.111385_bib23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2007.03.025","article-title":"The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T","volume":"256","author":"Hatayam","year":"2007","journal-title":"Biochem. Biphys. Res. Commun."},{"key":"10.1016\/j.biopha.2021.111385_bib24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3945\/jn.110.128504","article-title":"Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch","volume":"141","author":"McOrist","year":"2011","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2021.111385_bib25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1053\/j.gastro.2004.03.071","article-title":"Butyrate as an effective treatment of congenital chloride diarrhea","volume":"127","author":"Berni Canani","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2021.111385_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1572-0241.2007.01562_14.x","article-title":"Oral butyrate in treatment of congenital chloride diarrhea","volume":"103","author":"Wedenoja","year":"2008","journal-title":"AJG"},{"key":"10.1016\/j.biopha.2021.111385_bib27","first-page":"76","article-title":"SLC26A3 mutation in Turkish neonate and her sibling with congenital chloride diarrhea","volume":"55","author":"Do\u011fan","year":"2020","journal-title":"Turk. Pediatri Ars"},{"key":"10.1016\/j.biopha.2021.111385_bib28","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2021.111385_bib29","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1471-4159.2009.06212.x","article-title":"The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain","volume":"110","author":"Kim","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2021.111385_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/nu11020308","article-title":"Monobutyrin reduces liver cholesterol and improves intestinal barrier function in rats fed high-fat diets","volume":"11","author":"Nguyen","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2021.111385_bib31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00280-003-0580-5","article-title":"Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug","volume":"51","author":"Edelman","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111385_bib32","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1071\/AN14930","article-title":"Effects of supplementing a milk replacer with sodium butyrate or tributyrin on performance and metabolism of Holstein calves","volume":"56","author":"Araujo","year":"2016","journal-title":"Anim. Prod. Sci."},{"key":"10.1016\/j.biopha.2021.111385_bib33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1017\/S0954422410000247","article-title":"From the gut to the peripheral tissues: the multiple effects of butyrate","volume":"23","author":"Guilloteau","year":"2010","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.biopha.2021.111385_bib34","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3748\/wjg.v13.i7.1079","article-title":"A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon","volume":"13","author":"Roda","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.111385_bib35","unstructured":"R. Berni Canani, A. Calignano, O. Mazzoni, A. Coruzzo, Fatty Acid Derivatives for Oral Administration Endowed With High Palatability, in: Google Patents: WO2009130735A8, 2009."},{"key":"10.1016\/j.biopha.2021.111385_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1079\/PNS2002207","article-title":"Regulation of short-chain fatty acid production","volume":"62","author":"Macfarlane","year":"2003","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.biopha.2021.111385_bib37","unstructured":"REGULATION(EU) 2015\/2283 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 25 November 2015 on novel foods, Amending Regulation (EU) No 1169\/2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258\/97 of the European Parliament and of the Council and Commission Regulation (EC) No1852\/20. Official Journal of the European Union. 11.12.2015 L 327 1-22."},{"key":"10.1016\/j.biopha.2021.111385_bib38","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1039\/C3FO60702J","article-title":"A standardised static in vitro digestion method suitable for food \u2013 an international consensus","volume":"5","author":"Minekus","year":"2014","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2021.111385_bib39","unstructured":"OECD (Organisation for Economic Cooperation and Development), 2020. Guideline for Testing of Chemicals: Bacterial Reverse Mutation Test, pp. 1e11. Guideline 471."},{"key":"10.1016\/j.biopha.2021.111385_bib40","unstructured":"OECD (Organisation for Economic Cooperation and Development), 2016. Guideline for Testing of Chemicals: in Vitro Mammalian Cells Micronucleus Test, pp. 1e26. Guideline 487."},{"key":"10.1016\/j.biopha.2021.111385_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mrgentox.2006.04.002","article-title":"SFTG international collaborative study on the in vitro micronucleus test. III Using CHO cells","volume":"607","author":"Aardema","year":"2006","journal-title":"Mutat. Res."},{"key":"10.1016\/j.biopha.2021.111385_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/em.2850130104","article-title":"Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody","volume":"13","author":"Eastmond","year":"1989","journal-title":"Environ. Mol. Mutagen."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221001700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221001700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:37:35Z","timestamp":1760099855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221001700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":42,"alternative-id":["S0753332221001700"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111385","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo bioavailability and in vitro toxicological evaluation of the new butyric acid releaser N-(1-carbamoyl-2-phenyl-ethyl) butyramide","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111385"}}